Clinical Trials Logo

Clinical Trial Summary

The prognosis of patients with locally advanced SCCHN is poor. Results of recent randomized trials evaluating induction chemotherapy by docetaxel, cisplatin, 5 fluorouracil are conflicting, and benefit on overall survival is uncertain. Improve efficacy of induction chemotherapy is important without increase toxicities. Durvalumab is a promising agent in SSCHN. The safety of combination of docetaxel, cisplatin, 5 fluorouracil with durvalumab is unknown.

The aim of the study is to evaluate the feasibility and the safety of the association of DCF (standard regimen for induction in SSCCHN) and durvalumab. The safety profile of DCF and durvalumab are different, so the expected toxicities should not be additive. The addition of durvalumab to DCF could improve the efficacy of induction chemotherapy and the prognostic of patients with SSCCHN.

Concerning the translational research, the aim will be to explore the relationships between immune capacity, specificity, activation state and clinical outcome to help elucidate the determinants of response to immunotherapy.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT02997332
Study type Interventional
Source Gustave Roussy, Cancer Campus, Grand Paris
Contact Caroline EVEN, MD
Phone 0142116537
Email [email protected]
Status Recruiting
Phase Phase 1
Start date March 30, 2017
Completion date December 2019

See also
  Status Clinical Trial Phase
Terminated NCT00721539 - Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract N/A
Recruiting NCT00568490 - Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Completed NCT01135849 - B-Receptor Signaling in Cardiomyopathy N/A
Completed NCT00313027 - Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation N/A
Completed NCT00186433 - A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations N/A
Completed NCT02854358 - Efficacy of Traditional Persian Medicine Preparation Versus Artificial Saliva for Radiation Induced Xerostomia Phase 2
Terminated NCT01114256 - FNA Tumor Sampling for CD137 Modulation: A Pilot Study N/A
Terminated NCT00965003 - MRI Laryngeal Imaging With a Surface Coil Early Phase 1
Active, not recruiting NCT00490061 - Phase II Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy Phase 2
Completed NCT02045368 - Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R Phase 1
Completed NCT01908504 - Adaptive Pet Study N/A
Not yet recruiting NCT03394417 - StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients N/A
Active, not recruiting NCT00580203 - Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
Completed NCT00230295 - Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast N/A
Completed NCT00610415 - Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study N/A
Not yet recruiting NCT04565457 - A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality Early Phase 1
Completed NCT01664936 - Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes
Completed NCT01163487 - Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers Phase 1
Terminated NCT01137162 - Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors N/A
Active, not recruiting NCT02748707 - Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study Phase 2